BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11249669)

  • 1. Gene transfer with herpes simplex vectors.
    Lachmann RH; Efstathiou S
    Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
    Lachmann RH; Efstathiou S
    Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
    Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus vectors for gene transfer to the nervous system.
    Goins WF; Krisky D; Marconi P; Oligino T; Ramakrishnan R; Poliani PL; Fink DJ; Glorioso JC
    J Neurovirol; 1997 May; 3 Suppl 1():S80-8. PubMed ID: 9179803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
    Burton EA; Fink DJ; Glorioso JC
    Curr Opin Mol Ther; 2005 Aug; 7(4):326-36. PubMed ID: 16121698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
    Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
    Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minireview: the herpes simplex virus amplicon--a versatile defective virus vector.
    Frenkel N; Singer O; Kwong AD
    Gene Ther; 1994; 1 Suppl 1():S40-6. PubMed ID: 8542394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
    Oligino T; Ghivizzani S; Wolfe D; Lechman E; Krisky D; Mi Z; Evans C; Robbins P; Glorioso J
    Gene Ther; 1999 Oct; 6(10):1713-20. PubMed ID: 10516720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vector systems for gene therapy.
    Jolly D
    Cancer Gene Ther; 1994 Mar; 1(1):51-64. PubMed ID: 7621239
    [No Abstract]   [Full Text] [Related]  

  • 10. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
    Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
    Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production.
    Karpoff HM; Kooby D; D'Angelica M; Mack J; Presky DH; Brownlee MD; Federoff H; Fong Y
    Cancer Gene Ther; 2000 Apr; 7(4):581-8. PubMed ID: 10811476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.
    Ichikawa T; Chiocca EA
    Cancer Res; 2001 Jul; 61(14):5336-9. PubMed ID: 11454670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical application of herpes simplex virus.
    Watanabe D
    J Dermatol Sci; 2010 Feb; 57(2):75-82. PubMed ID: 19939634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy with herpes simplex virus vectors.
    Latchman DS
    Arch Immunol Ther Exp (Warsz); 1999; 47(6):335-40. PubMed ID: 10608288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication-competent herpes simplex vectors: design and applications.
    Argnani R; Lufino M; Manservigi M; Manservigi R
    Gene Ther; 2005 Oct; 12 Suppl 1():S170-7. PubMed ID: 16231051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.
    Krisky DM; Marconi PC; Oligino TJ; Rouse RJ; Fink DJ; Cohen JB; Watkins SC; Glorioso JC
    Gene Ther; 1998 Nov; 5(11):1517-30. PubMed ID: 9930305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex virus-based vectors.
    Lachmann R
    Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
    Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
    Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of neuronal physiology with defective herpes simplex virus vectors.
    Neve RL; Geller AI
    Adv Neurol; 1999; 79():1027-32. PubMed ID: 10514884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.